Barasa E

Indirect health effects of the COVID-19 pandemic in Kenya: a mixed methods assessment.Barasa E, Kazungu J, Orangi S, Kabia E, Ogero M, Kasera K
BMC Health Serv Res, (2021). 21:740

Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya.Adetifa IMO, Uyoga S, Gitonga JN, Mugo D, Otiende M, Nyagwange J, Karanja HK, Tuju J, Wanjiku P, Aman R, Mwangangi M, Amoth P, Kasera K, Ng'ang'a W, Rombo C, Yegon C, Kithi K, Odhiambo E, Rotich T, Orgut I, Kihara S, Bottomley C, Kagucia EW, Gallagher KE, Etyang A, Voller S, Lambe T, Wright D, Barasa E, Tsofa B, Bejon P, Ochola-Oyier LI, Agweyu A, Scott JAG, Warimwe GM
Nat Commun, (2021). 12:3966

Impact of free maternity policies in Kenya: an interrupted time-series analysis.Orangi S, Kairu A, Malla L, Ondera J, Mbuthia B, Ravishankar N, Barasa E
BMJ Glob Health, (2021). 6:e003649

An innovative leadership development initiative to support building everyday resilience in health systems.Nzinga J, Boga M, Kagwanja N, Waithaka D, Barasa E, Tsofa B, Gilson L, Molyneux S
Health Policy Plan, (2021). 36:1023-1035

A bibliometric analysis of COVID-19 research in Africa.Guleid FH, Oyando R, Kabia E, Mumbi A, Akech S, Barasa E
BMJ Glob Health, (2021). 6:e005690

Examining health sector application and utility of program-based budgeting: County level experiences in Kenya.Tsofa B, Musotsi P, Kagwanja N, Waithaka D, Molyneux S, Barasa E, Maina T, Chuma J
Int J Health Plann Manage, (2021). 36:1521-1532

How do healthcare providers respond to multiple funding flows? A conceptual framework and options to align them.Barasa E, Mathauer I, Kabia E, Ezumah N, Mbau R, Honda A, Dkhimi F, Onwujekwe O, Phuong HT, Hanson K
Health Policy Plan, (2021). 36:861-868

Health system responsiveness: a systematic evidence mapping review of the global literature.Khan G, Kagwanja N, Whyle E, Gilson L, Molyneux S, Schaay N, Tsofa B, Barasa E, Olivier J
Int J Equity Health, (2021). 20:112

Examining the level and inequality in health insurance coverage in 36 sub-Saharan African countries.Barasa E, Kazungu J, Nguhiu P, Ravishankar N
BMJ Glob Health, (2021). 6:e004712

Examining unit costs for COVID-19 case management in Kenya.Barasa E, Kairu A, Ng'ang'a W, Maritim M, Were V, Akech S, Mwangangi M
BMJ Glob Health, (2021). 6:e004159

Cost-effectiveness of community health systems strengthening: quality improvement interventions at community level to realise maternal and child health gains in Kenya.Kumar MB, Madan JJ, Auguste P, Taegtmeyer M, Otiso L, Ochieng CB, Muturi N, Mgamb E, Barasa E
BMJ Glob Health, (2021). 6:e002452

Collective sensemaking for action: researchers and decision makers working collaboratively to strengthen health systems.Gilson L, Barasa E, Brady L, Kagwanja N, Nxumalo N, Nzinga J, Molyneux S, Tsofa B
BMJ, (2021). 372:m4650

Unit costs and other musings: a response.Torres-Rueda S, Ferrari G, Orangi S, Hitimana R, Daviaud E, Tawiah T, Prah RKD, Karmaliani R, Kapapa E, Barasa E, Jewkes R, Vassall A
Health Policy Plan, (2021). 36:223-225

Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors.Uyoga S, Adetifa IMO, Karanja HK, Nyagwange J, Tuju J, Wanjiku P, Aman R, Mwangangi M, Amoth P, Kasera K, Ng'ang'a W, Rombo C, Yegon C, Kithi K, Odhiambo E, Rotich T, Orgut I, Kihara S, Otiende M, Bottomley C, Mupe ZN, Kagucia EW, Gallagher KE, Etyang A, Voller S, Gitonga JN, Mugo D, Agoti CN, Otieno E, Ndwiga L, Lambe T, Wright D, Barasa E, Tsofa B, Bejon P, Ochola-Oyier LI, Agweyu A, Scott JAG, Warimwe GM
Science, (2021). 371:79-82

Prevalence of anti-SARS-CoV-2 IgG antibodies among Kenyan blood donors between June and August 2021..Uyoga S, Otiende M, Adetifa IMO, Karanja HK, Gitonga J, Mugo D, Makale J, Tawa B, Singilai A, Nyagwange J, Tuju J, Aman R, Mwangangi M, Amoth P, Kasera K, Ng’ang’a W, Kilonzo N, Chege E, Yegon C, Rotich T, Orgut I, Kagucia EW, Gallagher KE, Etyang A, Voller S, Bottomley C, Lambe T, Wright D, Tsofa B, Mwangangi J, Barasa E, Bejon P, Ochola-Oyier LI, Warimwe GM, Scott JAG, Agweyu A
1st International Conference on Public Health in Africa (CPHIA), (2021). :

High anti-SARS-CoV-2 IgG antibody seroprevalence among long-distance trucking crews in Kenya within one year of the COVID-19 pandemic..Kagucia EW, Gitonga JN, Kalu C, Kuya N, Ochieng B, Karia B, Ochomo E, Karani A, Nyagwange J, Mugo D, Karanja HK, Tuju J, Mutiso A, Maroko H, Okubi L, Maitha E, Mukabi D, The TDA SARS-CoV-2 Serosurveillance Team, Aman R, Mwangangi M, Amoth P, Kasera K, Ng’ang’a W, Nyaguara A, Voller S, Otiende M, Bottomley C, Agoti CN, Ochola-Oyier LI, Adetifa IMO, Etyang AO, Gallagher KE, Uyoga S, Barasa E, Bejon P, Tsofa B, Agweyu A, Warimwe GM, Scott JAG
1st International Conference on Public Health in Africa (CPHIA), (2021). :

Experiences and response to the coronavirus disease 2019 (COVID 19) pandemic at private retail pharmacies in Kenya, 2020: a mixed methods study.Mugo P, Mumbi A, Munene D, Nzinga J, Molyneux S, Barasa E, on behalf of PSK CRT
1st International Conference on Public Health in Africa (CPHIA-2021), (2021). :

Serosurveillance for SARS-CoV-2 Antibodies in a cohort of Health Care Workers in Kenya..Etyang AO, Lucinde R, Gitonga JN, Kalu C, Karani A, Nyagwange J, Mugo D, Karanja HK, Tuju J, Mutiso A, Maroko H, Okubi L, Maitha E, Mukabi D, The HCW SARS-CoV-2 Serosurveillance Team, Aman R, Mwangangi M, Amoth P, Kasera K, Ng’ang’a W, Nyaguara A, Voller S, Otiende M, Bottomley C, Agoti CN, Ochola-Oyier LI, Adetifa IMO, Gallagher KE, Uyoga S, Barasa E, Bejon P, Tsofa B, Agweyu A, Warimwe GM, Scott JAG
1st International Conference on Public Health in Africa (CPHIA), (2021). :

Genomic surveillance of SARS-CoV-2 in Kenya: March 2020-October 2021..Githinji G, Lambisia WA, Mohamed KS, Morobe MJ, de Laurent ZR, Mburu WM, Ongera ME, Omuoyo OD, Ndwiga L, Otieno E, Murunga N, Musyoki J, KWTRP COVID Testing Team, Kilifi Rapid Response Team, Kiiru J, Kasera K, Amoth P, Mwangangi M, Aman R, Kinyanjui S, Warimwe GM, Agweyu A, Barasa E, Tsofa B, Mwangangi J, Matoke D, Nokes DJ, Bejon P, Ochola-Oyier LI, Agoti CN
1st International Conference on Public Health in Africa (CPHIA-2021), (2021). :

All-cause and cause-specific mortality in Kilifi Health and Demographic Surveillance System, in Kenya in the period of the COVID-19 pandemic..Otiende M, Nyagura A, Bottomley C, Walumbe D, Mochama G, Amadi D, Nyundo C, Kagucia W, Etyang AO, Adetifa IMO, Maitha E, Chondo E, Nzomo E, Aman R, Mwangangi M, Amoth P, Wangari N, Barasa E, Mwangangi J, Bejon P, Agweyu A, Williams TN, Scott JAG
1st International Conference on Public Health in Africa (CPHIA), (2021). :